United Therapeutic (UTHR)
$92.49 0.54 (0.58%)
16:44 EST UTHR Stock Quote Delayed 15 Minutes
Previous Close $92.49
Market Cap 4.03B
PE Ratio 8.42
Volume (Avg. Vol.) 443,235
Day's Range 92.26 - 94.58
52-Week Range 74.31 - 128.94
Dividend & Yield N/A (N/A)
UTHR Stock Predictions, Articles, and United Therapeutic News
- From InvestorPlace
- From the Web
Uncertainty is a constant risks for biotech stocks. Which ones matter? Some are down so much investors cannot ignore them now.
MannKind scored a collaboration deal with biotechnology giant, United Therapeutics. This development partnership could pay off big.
United Therapeutics (UTHR) shares skyrocketed Friday amidst rumors that the company may be the subject of a takeover by a pharma giant soon.
3D Systems is up more than 20% so far this year, but DDD stock needs a first-quarter earnings beat to keep the momentum rolling.
Why General Motors Company (GM), Acorda Therapeutics Inc (ACOR) and United Therapeutics Corporation (UTHR) Are 3 of Today’s Worst Stocks
Acorda Therapeutics (ACOR), General Motors (GM) and United Therapeutics (UTHR) investors ended up wishing last weekend was a three-day weekend.
The overall ratings of 52 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Healthcare stocks finished up 0.3% on Wall Street on Thursday.
Healthcare stocks finished up 1.5% on Wall Street on Wednesday.
Healthcare stocks finished up 0.3% on Wall Street today.
Healthcare stocks rose 0.8% on Wall Street on Wednesday morning.
Healthcare stocks declined broadly on Wall Street on Monday, with the sector seeing an overall decline of 1.7%.
Healthcare stocks finished down broadly on Wall Street on Monday, with the sector seeing an overall decline of 1.7%.
Healthcare stocks declined 1.9% on Wall Street today.
From Market News Video
From Simply Wall St
Anyone researching United Therapeutics Corporation (NASDAQ:UTHR) might want to consider the historical volatility of the share price. Modern finance theory considers volatility to be a measure of risk, and there<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-uthr/united-therapeutics/news/does-united-therapeutics-corporation-nasdaquthr-have-a-high-beta/">Read More...</a></div>
United Therapeutics Corporation Just Recorded A 23% EPS Beat: Here’s What Analysts Are Forecasting Next
From Simply Wall St
A week ago, United Therapeutics Corporation (NASDAQ:UTHR) came out with a strong set of quarterly numbers that could potentially lead to a re-rate of the stock. United Therapeutics delivered a<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-uthr/united-therapeutics/news/united-therapeutics-corporation-just-recorded-a-23-eps-beat-heres-what-analysts-are-forecasting-next/">Read More...</a></div>
Navellier RatingsPowered by Portfolio Grader